Close
Invesco Ltd: Form 8.3 - BHP Group Ltd. Apr 29, 2024 07:36AM

FORM 8.3

PUBLIC DEALING DISCLOSURE BYA PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”)

1.KEY INFORMATION   (a)Full name of discloser:Invesco Ltd. (b)Owner or controller of interests and short positions disclosed, if different from 1(a):The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.  (c)Name of offeror/offeree in... (continue reading...)
NowVertical Group Announces Delay in Annual Filings Apr 29, 2024 07:33AM

TORONTO, April 29, 2024 (GLOBE NEWSWIRE) -- NowVertical Group Inc. (TSXV: NOW) (OTCQB: NOWVF), (“NOW” or the “Company”), announces a delay in the filing of its audited annual financial statements, management's discussion and analysis and related chief executive officer (CEO) and chief financial officer (CFO) certifications (collectively, the "Annual Filings") for the financial year ended December 31, 2023, which were due today under Canadian securities law... (continue reading...)


Invesco Ltd: Form 8.3 - Anglo American PLC Public dealing disclosure Apr 29, 2024 07:31AM

FORM 8.3

PUBLIC DEALING DISCLOSURE BYA PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”)

1.KEY INFORMATION   (a)Full name of discloser:Invesco Ltd. (b)Owner or controller of interests and short positions disclosed, if different from 1(a):The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.  (c)Name of offeror/offeree in... (continue reading...)
Cognition Therapeutics Completes Enrollment in Phase 2 SHIMMER Study of CT1812 in Mild-to-Moderate Dementia with Lewy Bodies Apr 29, 2024 07:30AM

PURCHASE, N.Y., April 29, 2024 (GLOBE NEWSWIRE) -- Cognition Therapeutics, Inc. (the “Company” or “Cognition”) (NASDAQ: CGTX), a clinical stage company developing drugs that treat neurodegenerative disorders, today announced that the company has reached target enrollment in the randomized, placebo-controlled Phase 2 SHIMMER (COG1201) study (NCT05225415), which is examining the safety and effectiveness of CT1812 in adults with mild-to-moderate dementia with... (continue reading...)


KANZHUN LIMITED Files Its Annual Report on Form 20-F Apr 29, 2024 07:30AM

BEIJING, April 29, 2024 (GLOBE NEWSWIRE) -- KANZHUN LIMITED (“BOSS Zhipin” or the “Company”) (Nasdaq: BZ; HKEX: 2076), a leading online recruitment platform in China, today announced it filed its annual report on Form 20-F for the fiscal year ended December 31, 2023 with the Securities and Exchange Commission on April 29, 2024, U.S. Eastern Time. The annual report can be accessed on the Company’s investor relations website at https://ir.zhipin.com.

The... (continue reading...)


More Globe Newswire

View Older Stories

Apr 29, 2024 07:30AM Heartland Financial USA, Inc. ("HTLF") Reports Quarterly Results as of March 31, 2024
Apr 29, 2024 07:30AM Bioventus to Report First Quarter of Fiscal Year 2024 Financial Results on May 7, 2024
Apr 29, 2024 07:30AM Intellia Therapeutics to Present Updated Data from Phase 1/2 Study of NTLA-2002 for the Treatment of Hereditary Angioedema (HAE) at the EAACI Congress 2024
Apr 29, 2024 07:30AM UMB Announces Agreement to Acquire Heartland Financial
Apr 29, 2024 07:30AM Zevra Therapeutics’ President and Chief Executive Officer Issues Letter to Stockholders Highlighting Recent Key Accomplishments and Outlook for 2024
Apr 29, 2024 07:30AM Heartland Financial USA, Inc. ("HTLF") Reports Quarterly Results as of March 31, 2024
Apr 29, 2024 07:30AM Streamline Health® Expands eValuator™ Footprint With Existing Client
Apr 29, 2024 07:30AM Dragonfly Energy to Report First Quarter 2024 Financial and Operational Results on May 14, 2024
Apr 29, 2024 07:30AM Beji Varghese Joins FTI Consulting’s Financial Services Practice in Charlotte
Apr 29, 2024 07:30AM OJEMDA™ (tovorafenib) Now Available from Onco360 for the Treatment of Patients Six Months of Age and Older with Relapsed or Refractory Pediatric Low-Grade Glioma (LGG) Harboring a BRAF Fusion or Rea
Apr 29, 2024 07:29AM Form 8.3 - [LOK'N STORE GROUP PLC - 26 04 2024] - (CGWL)
Apr 29, 2024 07:30AM Scandinavian Tobacco Group A/S: Transactions in connection with share buy-back programme
Apr 29, 2024 07:25AM Bullet Blockchain Announces 2023 Financial Results
Apr 29, 2024 07:25AM Alterity Therapeutics Presents New Data Demonstrating Potential of ATH434 to Treat Rare Neurodegenerative Disease Friedreich’s Ataxia
Apr 29, 2024 07:15AM Form 8.3 - Mattioli Woods plc
Apr 29, 2024 07:15AM AirBoss Defense Group Receives $45 Million Order for the Bandolier Lightweight Multi-Purpose Energetic System
Apr 29, 2024 07:15AM QUIDELORTHO CORPORATION (NASDAQ: QDEL) DEADLINE ALERT: Bernstein Liebhard LLP Reminds QuidelOrtho Corporation Investors of Upcoming Deadline
Apr 29, 2024 07:15AM PERION NETWORK LTD. (NASDAQ: PERI) DEADLINE ALERT: Bernstein Liebhard LLP Reminds Perion Network Ltd. Investors of Upcoming Deadline
Apr 29, 2024 07:15AM GOODRX HOLDINGS, INC. (NASDAQ: GDRX) DEADLINE ALERT: Bernstein Liebhard LLP Reminds GoodRx Holdings, Inc. Investors of Upcoming Deadline
Apr 29, 2024 07:15AM LUNA INNOVATIONS INCORPORATED (NASDAQ: LUNA) DEADLINE ALERT: Bernstein Liebhard LLP Reminds Luna Innovations Incorporated Investors of Upcoming Deadline
Apr 29, 2024 07:15AM EVOLV TECHNOLOGIES HOLDINGS, INC. (NASDAQ: EVLV) DEADLINE ALERT: Bernstein Liebhard LLP Reminds Evolv Technologies Holdings, Inc. Investors of Upcoming Deadline
Apr 29, 2024 07:15AM BLUEBIRD BIO, INC. (NASDAQ: BLUE) DEADLINE ALERT: Bernstein Liebhard LLP Reminds bluebird bio, Inc. Investors of Upcoming Deadline
Apr 29, 2024 07:15AM RIVIAN AUTOMOTIVE, INC. (NASDAQ: RIVN) DEADLINE ALERT: Bernstein Liebhard LLP Reminds Rivian Automotive, Inc. Investors of Upcoming Deadline
Apr 29, 2024 07:15AM SSR MINING INC. (NASDAQ: SSRM) DEADLINE ALERT: Bernstein Liebhard LLP Reminds SSR Mining Inc. Investors of Upcoming Deadline
Apr 29, 2024 07:15AM THE CHEMOURS COMPANY (NYSE: CC) DEADLINE ALERT: Bernstein Liebhard LLP Reminds The Chemours Company Investors of Upcoming Deadline
Apr 29, 2024 07:15AM LINCOLN NATIONAL CORPORATION (NYSE: LNC) DEADLINE ALERT: Bernstein Liebhard LLP Reminds Lincoln National Corporation Investors of Upcoming Deadline
Apr 29, 2024 07:15AM AUTODESK, INC. (NASDAQ: ADSK) DEADLINE ALERT: Bernstein Liebhard LLP Reminds Autodesk, Inc. Investors of Upcoming Deadline
Apr 29, 2024 07:15AM DOXIMITY, INC. (NYSE: DOCS) DEADLINE ALERT: Bernstein Liebhard LLP Reminds Doximity, Inc. Investors of Upcoming Deadline
Apr 29, 2024 07:15AM ANAVEX LIFE SCIENCES CORPORATION (NASDAQ: AVXL) DEADLINE ALERT: Bernstein Liebhard LLP Reminds Anavex Life Sciences Corporation Investors of Upcoming Deadline
Apr 29, 2024 07:15AM COMPASS MINERALS INTERNATIONAL, INC. (NYSE: CMP) DEADLINE ALERT: Bernstein Liebhard LLP Reminds Compass Minerals International, Inc. Investors of Upcoming Deadline
Apr 29, 2024 07:15AM VINFAST AUTO LTD. (NASDAQ: VFS) DEADLINE ALERT: Bernstein Liebhard LLP Reminds VinFast Auto Ltd. Investors of Lead Plaintiff Deadline
Apr 29, 2024 07:15AM SHOALS TECHNOLOGIES GROUP, INC. (NASDAQ: SHLS) DEADLINE ALERT: Bernstein Liebhard LLP Reminds Shoals Technologies Group, Inc. Investors of Upcoming Deadline
Apr 29, 2024 07:15AM IROBOT CORPORATION (NASDAQ: IRBT) DEADLINE ALERT: Bernstein Liebhard LLP Reminds iRobot Corporation Investors of Upcoming Deadline
Apr 29, 2024 07:15AM Elior North America Unveils Second Annual Social & Environmental Responsibility Report
Apr 29, 2024 07:15AM Elior North America Unveils Second Annual Social & Environmental Responsibility Report
Apr 29, 2024 07:13AM Transactions in connection with share buyback programme
Apr 29, 2024 07:10AM Northland Power releases 2023 Sustainability Report highlighting ESG achievements
Apr 29, 2024 07:07AM EnviroGold Global Launches Private Placement and Announces Engagement with Sequoia Corporate Finance Pty Ltd
Apr 29, 2024 07:05AM Kraig Biocraft Laboratories Reports Signing Landmark Agreements in South East Asia
Apr 29, 2024 07:00AM CloudMD Announces Late Filing of Annual Financial Statements
Apr 29, 2024 07:00AM EYLEA® HD (aflibercept) Injection 8 mg Presentations at ARVO Reinforce Sustained and Clinically Meaningful Outcomes in Serious Retinal Diseases
Apr 29, 2024 07:00AM Atlas One Capital Corporation Releases Annual Financial Statements for FYE 2023
Apr 29, 2024 07:00AM West Red Lake Gold Outlines 2024 Regional Exploration Strategy for Madsen and Rowan
Apr 29, 2024 07:00AM Lithium Ionic Reports Exceptional Drill Results from Bandeira of 1.25% Li2O over 50m, 1.46% Li2O over 40m, 1.86% Li2O over 24m and 2.13% Li2O Over 20m; Minas Gerais, Brazil; Not included in latest MRE
Apr 29, 2024 07:00AM United Lithium Expands Holdings with Addition of Three Highly Prospective Properties in Finland and Sweden
Apr 29, 2024 07:00AM Lexicon Pharmaceuticals to Host First Quarter 2024 Financial Results Conference Call and Webcast on May 2, 2024
Apr 29, 2024 07:00AM Gritstone bio Announces Appointment of Stephen Webster to its Board of Directors
Apr 29, 2024 07:00AM Atea Announces Presentation of Data Highlighting Favorable Safety Profile of Bemnifosbuvir at ESCMID Global 2024
Apr 29, 2024 07:00AM AI Networking Innovator Nile Continues to Expand its Executive Team; Adding Stephen Patak as CRO and Surbhi Kaul as VP, Customer Experience
Apr 29, 2024 07:00AM Xtract One Technologies Awarded U.S. Department of Homeland Security SAFETY Act Designation for Multi-Sensor Gateway Portfolio
View Older Stories